Abstract
Purpose :
This study aimed to identify specific markers indicative of macular neural and microvascular alterations in individuals with Type 2 Diabetes Mellitus (T2DM) lacking clinically observable retinopathy.
Methods :
In this prospective observational study, all eyes underwent swept-source optical coherence tomography angiography (SS-OCTA) using the PLEX Elite 9000. Acquired images were quantitatively analyzed to compare macular neural and microvascular alterations in T2DM patients without retinopathy to age-matched controls. Precise assessments included measuring the thickness of each individual retinal layer and evaluating macular vascular indices within different capillary plexuses.
Results :
Forty-nine T2DM patients and 51 age-matched controls were recruited. T2DM patients showed a significant reduction in the mean macular thickness of the ganglion cell-inner plexiform layer (GC-IPL) (82.5 ± 5.5 μm vs. 86.2 ± 5.0 μm, p = 0.001) and macular retinal nerve fiber layer (RNFL) (45.8 ± 3.0 μm vs. 48.1 ± 3.7 μm, p = 0.001). Additionally, macular full retinal thickness was significantly lower in diabetic eyes than controls (324.9 ± 16.3 μm vs. 332.8 ± 13.7 μm, p = 0.009). Vascular measurements revealed subtle changes in macular vascular skeleton density within the total capillary plexuses in T2DM patients (0.132 ± 0.005 vs. 0.135 ± 0.005, p = 0.019).
Conclusions :
Metrics derived from SS-OCT, particularly macular RNFL and GC-IPL thicknesses, have proven to be superior indicators for the early detection of diabetic retinal disease in individuals with T2DM lacking clinically observable retinopathy. Further investigations are warranted to comprehensively understand the clinical implications of these findings.
This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.